How many insider declarations has Milbury Max A. filed?

Milbury Max A. has filed 3 public insider declarations with SEC (Form 4).

What is Milbury Max A.'s role?

Milbury Max A.'s reported role is not specified by the regulator across the filings.

Which companies does Milbury Max A. report trades for?

Milbury Max A. reports trades for ProMIS Neurosciences Inc..

What is Milbury Max A.'s declared buy vs sell volume?

Across the available history, declared buys total 13k€ and disposals 0.

← Executives ★ Sign in to follow

MM

Milbury Max A.

·SEC (Form 4)

ProMIS Neurosciences Inc.

0

申报总数

0

公司

€12,732

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-45.2%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the detailed record of transactions filed by Milbury Max A.. Director active across 1 company, notably ProMIS Neurosciences Inc.. In total, 3 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €13k. History available since 3 October 2025. The latest transaction was disclosed on 3 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Milbury Max A.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

ProMIS Neurosciences Inc. (US)

申报3 总计

◆

Milbury Max A.

高管2026年2月3日ProMIS Neurosciences Inc.

US$79,99712SEC ↗

6,595 股@ US$12.1384.2% 占其流量Common SharesSEC:0001104659-26-011137:0

▲

Milbury Max A.

高管2025年10月3日ProMIS Neurosciences Inc.

US$14,92914SEC ↗

30,392 股@ US$0.4912100.0% 占其流量Common SharesSEC:0001927056-25-000004:0

标准退出：2026年1月1日 (T+90)

◆

Milbury Max A.

Principal Accounting Officer高管2023年8月23日ProMIS Neurosciences Inc.

0SEC ↗

13,297 股Common SharesSEC:0000899243-23-018461:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MM

Milbury Max A.

·SEC (Form 4)

ProMIS Neurosciences Inc.

0

申报总数

0

公司

€12,732

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-45.2%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the detailed record of transactions filed by Milbury Max A.. Director active across 1 company, notably ProMIS Neurosciences Inc.. In total, 3 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €13k. History available since 3 October 2025. The latest transaction was disclosed on 3 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.